http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-142085-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_427556bd36ddf3c314f8888eebb7ef81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f7920b13c87bcdc8242fc19bdf4358b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d78e03cc1e994a21bd7dace1921ad8ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da156124da7bd8724b7cbd6332cbadbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a7fd2923c9bdbac3f262bd97957c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863f3705abb33ae8bada3651e7968a2e
publicationDate 2010-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-142085-A
titleOfInvention Imidazole derivatives
abstract THE PRESENT INVENTION RELATES TO IMIDA:ZOLE DERIVATIVES OF THE GENERAL FORMULA WHEREIN R1, R2, R3 AND R4 ARE AS DEFINED IN THE DESCRIPTION AS WELL AS PHARMACEUTICALLY ACCEPTABLE SALTS AND PROCESSES FOR THE PREPARATION THEREOF. THE INVENTION ALSO RELATES TO MEDICAMENTS CONTAINING SAID IMIDAZOLE DERIVATIVES AND TO THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT AND PREVENTION OF MGLUR5 RECEPTOR MEDIATED DISORDERS SUCH AS ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS, IN PARTICULAR ANXIETY, OR FOR THE TREATMENT OF CHRONIC AND ACUTE PAIN.
priorityDate 2003-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108071
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24418
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2915

Total number of triples: 31.